Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
Clin Infect Dis
    May 2018
  1. ZHAO Y, Wu Z, McGoogan JM, Sha Y, et al
    Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011-2015.
    Clin Infect Dis. 2018 May 16. pii: 4996605. doi: 10.1093.
    >> Share

  2. ELLIOT ER, Wang X, Singh S, Simmons B, et al
    Increased dolutegravir peak concentrations in people living with HIV aged 60 and over and analysis of sleep quality and cognition.
    Clin Infect Dis. 2018 May 16. pii: 4996575. doi: 10.1093.
    >> Share

  3. LAMBERT-NICLOT S, Grude M, Meynard JL, Marcelin AG, et al
    Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.
    Clin Infect Dis. 2018 May 15. pii: 4996083. doi: 10.1093.
    >> Share

  4. OWENS RL, Hicks CB
    A Wake-up Call for Human Immunodeficiency Virus (HIV) Providers: Obstructive Sleep Apnea in People Living With HIV.
    Clin Infect Dis. 2018 May 9. pii: 4994301. doi: 10.1093.
    >> Share

  5. SIMONSEN L, Higgs E, Taylor RJ, Wentworth D, et al
    Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
    Clin Infect Dis. 2018 May 8. pii: 4993975. doi: 10.1093.
    >> Share

  6. LUONG NGUYEN LB, Yazdanpanah Y, Maman D, Wanjala S, et al
    Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
    Clin Infect Dis. 2018 May 8. pii: 4994303. doi: 10.1093.
    >> Share

  7. CORNELISSE VJ, Fairley CK, Stoove M, Asselin J, et al
    Evaluation of PrEP eligibility criteria using sexually transmissible infections as HIV risk markers at enrolment in PrEPX, a large Australian HIV pre-exposure prophylaxis trial.
    Clin Infect Dis. 2018 May 7. pii: 4993324. doi: 10.1093.
    >> Share

  8. KOSS CA, Ayieko J, Mwangwa F, Owaraganise A, et al
    Early Adopters of HIV Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda.
    Clin Infect Dis. 2018 May 5. pii: 4993212. doi: 10.1093.
    >> Share

    April 2018
  9. ROSITCH AF, Jiang S, Coghill AE, Suneja G, et al
    Disparities and determinants of cancer treatment in elderly Americans living with HIV/AIDS.
    Clin Infect Dis. 2018 Apr 27. pii: 4987477. doi: 10.1093.
    >> Share

  10. SANFORD R, Ances BM, Meyerhoff DJ, Price RW, et al
    Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary HIV Infection.
    Clin Infect Dis. 2018 Apr 24. pii: 4984654. doi: 10.1093.
    >> Share

  11. NOVAK RM, Ghanem A, Hart R, Ward D, et al
    Risk factors and incidence of syphilis in HIV-infected persons, the HIV Outpatient Study, 1999-2015.
    Clin Infect Dis. 2018 Apr 24. pii: 4982945. doi: 10.1093.
    >> Share

  12. LEE YL, Chen GJ, Chen NY, Liou BH, et al
    Less Severe but Prolonged Course of Acute Hepatitis A in HIV-positive Patients than HIV-negative Patients During an Outbreak: A Multicenter Observational Study.
    Clin Infect Dis. 2018 Apr 17. pii: 4972863. doi: 10.1093.
    >> Share

  13. BA S, Raugi DN, Smith RA, Sall F, et al
    A Trial of a Single Tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of HIV-2 Infection in a Resource-Limited Setting: 48 Week Results from Senegal, West Africa.
    Clin Infect Dis. 2018 Apr 17. pii: 4972860. doi: 10.1093.
    >> Share

  14. RONIT A, Gerstoft J, Nielsen L, Mohey R, et al
    Non-AIDS Comorbidity in People Living with HIV Compared to Uninfected Individuals Ten Years Prior to HIV-Diagnosis.
    Clin Infect Dis. 2018 Apr 17. pii: 4972861. doi: 10.1093.
    >> Share

  15. PATTON ME, Bernstein K, Liu G, Zaidi A, et al
    Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women and sexually active, non-pregnant women in the United States.
    Clin Infect Dis. 2018 Apr 16. pii: 4970884. doi: 10.1093.
    >> Share

  16. CILLONIZ C, Miguel-Escuder L, Pedro-Bonet ML, Falco V, et al
    Community-Acquired Legionella Pneumonia in HIV-Infected Adult Patients: A Matched Case-Control Study.
    Clin Infect Dis. 2018 Apr 12. pii: 4969370. doi: 10.1093.
    >> Share

  17. RANE MS, Hong T, Govere S, Thulare H, et al
    Depression and anxiety as risk factors for delayed care-seeking behavior in HIV positive individuals in South Africa.
    Clin Infect Dis. 2018 Apr 12. pii: 4969307. doi: 10.1093.
    >> Share

  18. ROY M, Holmes C, Sikazwe I, Savory T, et al
    Application of a multi-state model to Evaluate Visit Burden and Patient Stability to Improve Sustainability of HIV Treatment in Zambia.
    Clin Infect Dis. 2018 Apr 7. pii: 4964003. doi: 10.1093.
    >> Share

  19. SEROTA DP, Rosenberg ES, Lockard AM, Rolle CM, et al
    Beyond the Biomedical: PrEP Failures in a Cohort of Young Black Men who have Sex with Men in Atlanta, GA.
    Clin Infect Dis. 2018 Apr 7. pii: 4964699. doi: 10.1093.
    >> Share

  20. WILKIN TJ, Chen H, Cespedes MS, Leon-Cruz JT, et al
    A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults age 27 years or older: AIDS Clinical Trials Group protocol A5298.
    Clin Infect Dis. 2018 Apr 5. pii: 4961357. doi: 10.1093.
    >> Share

  21. WOOD LF, Brown BP, Lennard K, Karaoz U, et al
    Feeding-related gut microbial composition associates with peripheral T cell activation and mucosal gene expression in African infants.
    Clin Infect Dis. 2018 Apr 5. pii: 4961341. doi: 10.1093.
    >> Share

  22. MELLIEZ H, Mary-Krause M, Bocket L, Guiguet M, et al
    Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
    Clin Infect Dis. 2018 Apr 4. pii: 4960877. doi: 10.1093.
    >> Share

  23. MUKERJI SS, Misra V, Lorenz DR, Uno H, et al
    Impact of Antiretroviral Regimens on CSF Viral Escape in a Prospective Multicohort Study of ART-Experienced HIV-1 Infected Adults in the United States.
    Clin Infect Dis. 2018 Apr 3. pii: 4959767. doi: 10.1093.
    >> Share

  24. KAUFMAN MR, Patel EU, Dam KH, Packman ZR, et al
    Impact of Counseling Received by Adolescents Undergoing Voluntary Medical Male Circumcision on Knowledge and Sexual Intentions.
    Clin Infect Dis. 2018;66.
    >> Share

  25. VAN LITH LM, Mallalieu EC, Patel EU, Dam KH, et al
    Perceived Quality of In-Service Communication and Counseling Among Adolescents Undergoing Voluntary Medical Male Circumcision.
    Clin Infect Dis. 2018;66.
    >> Share

  26. DAM KH, Kaufman MR, Patel EU, Van Lith LM, et al
    Parental Communication, Engagement, and Support During the Adolescent Voluntary Medical Male Circumcision Experience.
    Clin Infect Dis. 2018;66.
    >> Share

  27. NJEUHMELI E, Opuni M, Schnure M, Tchuenche M, et al
    Scaling Up Voluntary Medical Male Circumcision for Human Immunodeficiency Virus Prevention for Adolescents and Young Adult Men: A Modeling Analysis of Implementation and Impact in Selected Countries.
    Clin Infect Dis. 2018;66.
    >> Share

  28. MAVHU W, Hatzold K, Dam KH, Kaufman MR, et al
    Adolescent Wound-Care Self-Efficacy and Practices After Voluntary Medical Male Circumcision-A Multicountry Assessment.
    Clin Infect Dis. 2018;66.
    >> Share

  29. KAUFMAN MR, Patel EU, Dam KH, Packman ZR, et al
    Counseling Received by Adolescents Undergoing Voluntary Medical Male Circumcision: Moving Toward Age-Equitable Comprehensive Human Immunodeficiency Virus Prevention Measures.
    Clin Infect Dis. 2018;66.
    >> Share

  30. PATEL EU, Kaufman MR, Dam KH, Van Lith LM, et al
    Age Differences in Perceptions of and Motivations for Voluntary Medical Male Circumcision Among Adolescents in South Africa, Tanzania, and Zimbabwe.
    Clin Infect Dis. 2018;66.
    >> Share

  31. LANE C, Bailey RC, Luo C, Parks N, et al
    Adolescent Male Circumcision for HIV Prevention in High Priority Countries: Opportunities for Improvement.
    Clin Infect Dis. 2018;66.
    >> Share

  32. KAUFMAN MR, Dam KH, Sharma K, Van Lith LM, et al
    Females' Peer Influence and Support for Adolescent Males Receiving Voluntary Medical Male Circumcision Services.
    Clin Infect Dis. 2018;66.
    >> Share

  33. TOBIAN AAR, Dam KH, Van Lith LM, Hatzold K, et al
    Providers' Perceptions and Training Needs for Counseling Adolescents Undergoing Voluntary Medical Male Circumcision.
    Clin Infect Dis. 2018;66.
    >> Share

    March 2018
  34. MILLS JC, Pence BW, Todd JV, Bengtson AM, et al
    Cumulative Burden of Depression and All-Cause Mortality in Women Living with HIV.
    Clin Infect Dis. 2018 Mar 30. pii: 4956714. doi: 10.1093.
    >> Share

  35. VAN LAARHOVEN A, Koeken VACM, Dian S, Ganiem AR, et al
    Neuromarker Levels Also Predict Mortality in Adult Tuberculous Meningitis.
    Clin Infect Dis. 2018 Mar 30. pii: 4956701. doi: 10.1093.
    >> Share

  36. JOHNSON KT, Churchyard GJ, Sohn H, Dowdy DW, et al
    Cost-effectiveness of preventive therapy for tuberculosis with isoniazid and rifapentine versus isoniazid alone in high-burden settings.
    Clin Infect Dis. 2018 Mar 30. pii: 4956926. doi: 10.1093.
    >> Share

  37. SOHN AH, Kerr SJ, Hansudewechakul R, Gatechompol S, et al
    Risk Factors for Human Papillomavirus Infection and Abnormal Cervical Cytology Among Perinatally Human Immunodeficiency Virus-Infected and Uninfected Asian Youth.
    Clin Infect Dis. 2018 Mar 30. pii: 4956717. doi: 10.1093.
    >> Share

  38. BENSON CA, Andersen JW, Macatangay BJC, Mailliard RB, et al
    Safety and Immunogenicity of Zoster Vaccine Live in HIV-Infected Adults with CD4+ Cell Counts Above 200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 26. pii: 4953774. doi: 10.1093.
    >> Share

  39. MATHERON S, Descamps D, Gallien S, Besseghir A, et al
    First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).
    Clin Infect Dis. 2018 Mar 24. pii: 4953343. doi: 10.1093.
    >> Share

  40. SHIVAKOTI R, Gupte N, Kumar NP, Kulkarni V, et al
    Intestinal barrier dysfunction and microbial translocation in HIV-infected pregnant women is associated with preterm birth.
    Clin Infect Dis. 2018 Mar 24. pii: 4953365. doi: 10.1093.
    >> Share

  41. ROCKSTROH JK, Lacombe K, Viani RM, Orkin C, et al
    Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.
    Clin Infect Dis. 2018 Mar 16. pii: 4939381. doi: 10.1093.
    >> Share

  42. SAVIC RM, Jagannathan P, Kajubi R, Huang L, et al
    Intermittent Preventive Treatment for Malaria in Pregnancy: Optimization of Target Concentrations of Dihydroartemisinin-Piperaquine.
    Clin Infect Dis. 2018 Mar 14. pii: 4933916. doi: 10.1093.
    >> Share

  43. ARENAS-PINTO A, Grund B, Sharma S, Martinez E, et al
    Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
    Clin Infect Dis. 2018 Mar 12. pii: 4930647. doi: 10.1093.
    >> Share

  44. HSU DC, Breglio KF, Pei L, Wong CS, et al
    Emergence of Polyfunctional Cytotoxic CD4+ T Cells in Mycobacterium avium Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients.
    Clin Infect Dis. 2018 Mar 10. pii: 4925763. doi: 10.1093.
    >> Share

  45. LOZIER MJ, Rosenberg ES, Doyle K, Adams L, et al
    Prolonged detection of Zika virus nucleic acid among symptomatic pregnant women: a cohort study.
    Clin Infect Dis. 2018 Mar 9. pii: 4925247. doi: 10.1093.
    >> Share

  46. ALVI RM, Tariq N, Malhotra A, Awadalla M, et al
    Sleep Apnea and Heart Failure with a Reduced Ejection Fraction Among Persons Living with HIV.
    Clin Infect Dis. 2018 Mar 9. pii: 4925302. doi: 10.1093.
    >> Share

  47. KLEINSTEIN SE, Shea PR, Stamm LM, Sulkowski M, et al
    Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
    Clin Infect Dis. 2018 Mar 7. pii: 4705930. doi: 10.1093/cid/cix1051.
    >> Share

  48. MOGALIAN E, Stamm LM, Osinusi A, Brainard DM, et al
    Drug-Drug Interactions Studies between HCV Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted HIV Antiretroviral Regimens in Healthy Volunteers.
    Clin Infect Dis. 2018 Mar 7. pii: 4924529. doi: 10.1093.
    >> Share

  49. OUSLEY J, Niyibizi AA, Wanjala S, Vandenbulcke A, et al
    High Proportions of Patients With Advanced HIV Are Antiretroviral Therapy Experienced: Hospitalization Outcomes From 2 Sub-Saharan African Sites.
    Clin Infect Dis. 2018;66.
    >> Share

  50. CARMONA S, Bor J, Nattey C, Maughan-Brown B, et al
    Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort.
    Clin Infect Dis. 2018;66.
    >> Share

  51. FRIGATI L, Archary M, Rabie H, Penazzato M, et al
    Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Clin Infect Dis. 2018;66.
    >> Share

  52. FORD N, Shubber Z, Jarvis JN, Chiller T, et al
    CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2018;66.
    >> Share

  53. SIIKA A, McCabe L, Bwakura-Dangarembizi M, Kityo C, et al
    Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.
    Clin Infect Dis. 2018;66.
    >> Share

  54. POST FA, Szubert AJ, Prendergast AJ, Johnston V, et al
    Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
    Clin Infect Dis. 2018;66.
    >> Share

  55. OSLER M, Hilderbrand K, Goemaere E, Ford N, et al
    The Continuing Burden of Advanced HIV Disease Over 10 Years of Increasing Antiretroviral Therapy Coverage in South Africa.
    Clin Infect Dis. 2018;66.
    >> Share

  56. FORD N, Meintjes G, Calmy A, Bygrave H, et al
    Managing Advanced HIV Disease in a Public Health Approach.
    Clin Infect Dis. 2018;66.
    >> Share

  57. CALMY A, Ford N, Meintjes G
    The Persistent Challenge of Advanced HIV Disease and AIDS in the Era of Antiretroviral Therapy.
    Clin Infect Dis. 2018;66.
    >> Share

  58. SEKAGGYA-WILTSHIRE C, von Braun A, Lamorde M, Ledergerber B, et al
    Delayed Sputum Conversion in TB-HIV Co-Infected Patients with Low Isoniazid and Rifampicin Concentrations.
    Clin Infect Dis. 2018 Mar 3. pii: 4919550. doi: 10.1093.
    >> Share

  59. MUTOH Y, Nishijima T, Inaba Y, Tanaka N, et al
    Incomplete Recovery of CD4 count, CD4 Percentage, and CD4/CD8 ratio in HIV-Infected Patients on Long-Term Antiretroviral Therapy with Suppressed Viremia.
    Clin Infect Dis. 2018 Mar 2. pii: 4917726. doi: 10.1093.
    >> Share

  60. TRAEGER MW, Schroeder SE, Wright EJ, Hellard ME, et al
    Effects of Pre-exposure Prophylaxis for the Prevention of HIV Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2018 Mar 2. pii: 4917600. doi: 10.1093.
    >> Share

  61. LETENDRE S, Bharti A, Perez-Valero I, Hanson B, et al
    Higher Anti-CMV IgG Concentrations are Associated with Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 1. pii: 4915913. doi: 10.1093.
    >> Share

  62. RUSIE LK, Orengo C, Burrell D, Ramachandran A, et al
    PrEP Initiation and Retention in care over five years, 2012-2017: Are quarterly visits too much?
    Clin Infect Dis. 2018 Mar 1. pii: 4915901. doi: 10.1093.
    >> Share

    February 2018
  63. MWENDA R, Fong Y, Magombo T, Saka E, et al
    Significant Patient Impact Observed Upon Implementation of Point-Of-Care Early Infant Diagnosis Technologies in an Observational Study in Malawi.
    Clin Infect Dis. 2018 Feb 27. pii: 4911493. doi: 10.1093.
    >> Share

  64. SUN J, Brown TT, Samuels DC, Hulgan T, et al
    The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed Among Older Men Living with HIV.
    Clin Infect Dis. 2018 Feb 22. pii: 4898130. doi: 10.1093.
    >> Share

  65. CHRISTOPOULOS KA, Riley ED, Carrico AW, Tulsky J, et al
    A Randomized Controlled Trial of a Text Messaging Intervention to Promote Virologic Suppression and Retention in Care in an Urban Safety-Net HIV Clinic: The Connect4Care (C4C) Trial.
    Clin Infect Dis. 2018 Feb 21. pii: 4883333. doi: 10.1093.
    >> Share

  66. GELPI M, Afzal S, Lundgren J, Ronit A, et al
    Higher Risk of Abdominal Obesity, Elevated LDL Cholesterol and Hypertriglyceridemia, but not of Hypertension, in People Living with HIV: Results from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study.
    Clin Infect Dis. 2018 Feb 17. pii: 4868532. doi: 10.1093.
    >> Share

  67. MANUZAK JA, Gott TM, Kirkwood JS, Coronado E, et al
    Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
    Clin Infect Dis. 2018 Feb 17. pii: 4869752. doi: 10.1093/cid/cix1116.
    >> Share

  68. BAROCAS JA, Tasillo A, Eftekhari Yazdi G, Wang J, et al
    Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
    Clin Infect Dis. 2018 Feb 6. pii: 4840186. doi: 10.1093.
    >> Share

  69. CHAMBERS LC, Khosropour CM, Katz DA, Dombrowski JC, et al
    Racial/ethnic disparities in the lifetime risk of Chlamydia trachomatis diagnosis and adverse reproductive health outcomes among women in King County, Washington.
    Clin Infect Dis. 2018 Feb 6. pii: 4840254. doi: 10.1093.
    >> Share

  70. GRANT RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, et al
    Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.
    Clin Infect Dis. 2018 Feb 6. pii: 4840078. doi: 10.1093/cid/cix1086.
    >> Share

  71. QI Q, Hua S, Clish CB, Scott JM, et al
    Plasma tryptophan-kynurenine metabolites are altered in HIV infection and associated with progression of carotid artery atherosclerosis.
    Clin Infect Dis. 2018 Feb 3. pii: 4837274. doi: 10.1093.
    >> Share

  72. BROOKS KM, George JM, Pau AK, Rupert A, et al
    Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir with Once-Weekly Isoniazid and Rifapentine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836314. doi: 10.1093.
    >> Share

  73. GLIDDEN DV, Mulligan K, McMahan V, Anderson PL, et al
    Metabolic Effects of Pre-Exposure Prophylaxis with Co-Formulated Tenofovir Disoproxal Fumarate and Emtricitabine.
    Clin Infect Dis. 2018 Feb 3. pii: 4836821. doi: 10.1093.
    >> Share

  74. DINH TH, Mushavi A, Shiraishi RW, Tippett Barr B, et al
    Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother-Infant Pairs During the Transition
    Clin Infect Dis. 2018;66:576-585.
    >> Share

    January 2018
  75. ANDERSON AM, Tyor WR, Mulligan MJ, Waldrop-Valverde D, et al
    HIV p24 antigen is quantifiable at low concentrations in human cerebrospinal fluid with digital ELISA and is associated with decreased neuropsychological performance.
    Clin Infect Dis. 2018 Jan 29. pii: 4828064. doi: 10.1093.
    >> Share


  76. Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs.
    Clin Infect Dis. 2018 Jan 25. pii: 4823847. doi: 10.1093.
    >> Share

  77. KENYON C
    Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programs.
    Clin Infect Dis. 2018 Jan 23. pii: 4821305. doi: 10.1093.
    >> Share

  78. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Moving Forward with Treatment of Gonorrhea for Users of HIV Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.
    Clin Infect Dis. 2018 Jan 23. pii: 4821306. doi: 10.1093.
    >> Share

  79. HOSSEINIPOUR MC, Kang M, Krown SE, Bukuru A, et al
    As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jan 22. pii: 4819203. doi: 10.1093.
    >> Share

  80. FERRETTI F, Bestetti A, Yiannoutsos CT, Musick BS, et al
    Diagnostic and prognostic value of JC virus DNA in plasma in Progressive Multifocal Leukoencephalopathy.
    Clin Infect Dis. 2018 Jan 15. pii: 4808594. doi: 10.1093.
    >> Share

  81. HSU KK, Molotnikov LE, Roosevelt KA, Elder HR, et al
    Characteristics of Cases with Repeated Sexually Transmitted Infections, Massachusetts, 2014-2016.
    Clin Infect Dis. 2018 Jan 13. pii: 4805962. doi: 10.1093.
    >> Share

  82. MARAIS S, Roos I, Mitha A, Mabusha SJ, et al
    Spinal tuberculosis: Clinicoradiological findings in 274 patients.
    Clin Infect Dis. 2018 Jan 11. pii: 4797620. doi: 10.1093.
    >> Share

  83. MAHALE P, Engels EA, Coghill AE, Kahn AR, et al
    Cancer risk in older people living with human immunodeficiency virus infection in the United States.
    Clin Infect Dis. 2018 Jan 8. pii: 4793024. doi: 10.1093.
    >> Share

  84. NACHEGA JB, Sam-Agudu NA, Mofenson LM, Schechter M, et al
    Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities.
    Clin Infect Dis. 2018 Jan 8. pii: 4793055. doi: 10.1093.
    >> Share

  85. BARDENHEIER BH, McNeil MM, Wodi AP, McNicholl JM, et al
    Reply to Burgner, et al.
    Clin Infect Dis. 2018;66:319.
    >> Share

  86. MEHTA K, Im A, Rahman F, Wang H, et al
    Epidemiology and Outcomes of Hematopoietic Stem Cell Transplant in HIV (+) Patients from 1998 to 2012: A Nationwide Analysis.
    Clin Infect Dis. 2018 Jan 6. pii: 4792772. doi: 10.1093.
    >> Share

  87. LACOURSE SM, Cranmer LM, Njuguna IN, Gatimu J, et al
    Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.
    Clin Infect Dis. 2018 Jan 6. pii: 4792803. doi: 10.1093.
    >> Share

  88. COLE JH, Caan MWA, Underwood J, De Francesco D, et al
    No evidence for accelerated ageing-related brain pathology in treated HIV: longitudinal neuroimaging results from the Comorbidity in Relation to AIDS (COBRA) project.
    Clin Infect Dis. 2018 Jan 4. pii: 4788363. doi: 10.1093/cid/cix1124.
    >> Share

    December 2017
  89. BRUST JCM, Shah NS, Mlisana K, Moodley P, et al
    Improved survival and cure rates with concurrent treatment for MDR-TB/HIV co-infection in South Africa.
    Clin Infect Dis. 2017 Dec 26. pii: 4774985. doi: 10.1093/cid/cix1125.
    >> Share

  90. TAIWO BO, Marconi VC, Berzins B, Moser CB, et al
    Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial.
    Clin Infect Dis. 2017 Dec 26. pii: 4775007. doi: 10.1093/cid/cix1131.
    >> Share

  91. TRAN T, Guardigni V, Pencina KM, Amato AA, et al
    Atypical Skeletal Muscle Profiles in HIV+ Asymptomatic Middle-Aged Adults.
    Clin Infect Dis. 2017 Dec 25. pii: 4774570. doi: 10.1093/cid/cix1121.
    >> Share

  92. LIN TC, Gianella S, Tenenbaum T, Little SJ, et al
    A Simple Symptom Score for Acute HIV Infection in a San Diego Community Based Screening Program.
    Clin Infect Dis. 2017 Dec 25. pii: 4774597. doi: 10.1093/cid/cix1130.
    >> Share

  93. ARIKAWA S, Rollins N, Jourdain G, Humphrey J, et al
    Contribution of maternal ART and breastfeeding to 24-month survival in HIV-exposed uninfected children: an individual pooled analysis of African and Asian studies.
    Clin Infect Dis. 2017 Dec 21. pii: 4768415. doi: 10.1093/cid/cix1102.
    >> Share

  94. UNAL G, Alessandri-Gradt E, Leoz M, Pavie J, et al
    HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
    Clin Infect Dis. 2017 Dec 21. pii: 4768322. doi: 10.1093/cid/cix1087.
    >> Share

  95. HUA S, Vigano S, Tse S, Zhengyu O, et al
    Pegylated IFN-alpha-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients.
    Clin Infect Dis. 2017 Dec 20. pii: 4767848. doi: 10.1093/cid/cix1111.
    >> Share

  96. GREENE SA, McGrath CJ, Lehman DA, Marson KG, et al
    Increased Cervical HIV RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure (LEEP) compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3.
    Clin Infect Dis. 2017 Dec 20. pii: 4767844. doi: 10.1093/cid/cix1096.
    >> Share

  97. STOCKDALE AJ, Saunders MJ, Boyd MA, Bonnett LJ, et al
    Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of HIV-1 infection in sub-Saharan Africa: systematic review and meta-analysis.
    Clin Infect Dis. 2017 Dec 20. pii: 4767830. doi: 10.1093/cid/cix1108.
    >> Share

  98. YEGANEH N, Kerin T, Ank B, Watts H, et al
    HIV antiretroviral resistance and transmission in mother-infant pairs enrolled in a large perinatal study.
    Clin Infect Dis. 2017 Dec 19. pii: 4762480. doi: 10.1093/cid/cix1104.
    >> Share

  99. MADHI SA, Cutland CL, Downs S, Jones S, et al
    Burden of respiratory syncytial virus infection in South African HIV-infected and HIV-uninfected pregnant and post-partum women: A longitudinal cohort study.
    Clin Infect Dis. 2017 Dec 15. pii: 4749671. doi: 10.1093/cid/cix1088.
    >> Share

  100. TAIWO BO, Zheng L, Stefanescu A, Nyaku A, et al
    ACTG A5353: A pilot study of dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA < 500,000 copies/mL.
    Clin Infect Dis. 2017 Dec 14. pii: 4743559. doi: 10.1093/cid/cix1083.
    >> Share

  101. RAYMOND S, Nicot F, Pallier C, Bellecave P, et al
    Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
    Clin Infect Dis. 2017 Dec 13. pii: 4736156. doi: 10.1093/cid/cix1070.
    >> Share

  102. MOULIGNIER A, Savatovsky J, Assoumou L, Lescure FX, et al
    Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals.
    Clin Infect Dis. 2017 Dec 13. pii: 4737216. doi: 10.1093/cid/cix1075.
    >> Share

  103. CROWELL TA, Colby DJ, Pinyakorn S, Fletcher JLK, et al
    Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.
    Clin Infect Dis. 2017 Dec 7. pii: 4706268. doi: 10.1093/cid/cix1063.
    >> Share

  104. RICKLES M, Rebeiro PF, Sizemore L, Juarez P, et al
    Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic.
    Clin Infect Dis. 2017 Dec 7. pii: 4706246. doi: 10.1093/cid/cix1079.
    >> Share

  105. MA Y, Dou Z, Guo W, Mao Y, et al
    The Human Immunodeficiency Virus Care Continuum in China: 1985-2015.
    Clin Infect Dis. 2017 Dec 5. pii: 4693542. doi: 10.1093.
    >> Share

  106. ROUET F, Nouhin J, Zheng DP, Roche B, et al
    Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015.
    Clin Infect Dis. 2017 Dec 4. pii: 4689456. doi: 10.1093/cid/cix1071.
    >> Share

  107. NOVELLI S, Lecuroux C, Avettand-Fenoel V, Seng R, et al
    Long-term therapeutic impact of the timing of ART in patients diagnosed with primary HIV-1 infection.
    Clin Infect Dis. 2017 Dec 2. pii: 4683678. doi: 10.1093/cid/cix1068.
    >> Share

    November 2017
  108. BHATIA P, Temple J, Kantor M
    Not your garden-variety bacteremia: Gardnerella in an immunocompromised man.
    Clin Infect Dis. 2017 Nov 29. pii: 4675229. doi: 10.1093/cid/cix1054.
    >> Share

  109. BRANSON BM, Chavez PR, Hanscom B, Greene E, et al
    Expanding hospital HIV testing in the Bronx, New York and Washington, D.C.: Results from the HPTN 065 study.
    Clin Infect Dis. 2017 Nov 27. pii: 4668360. doi: 10.1093/cid/cix1053.
    >> Share

  110. VANDORMAEL A, Barnighausen T, Herbeck J, Tomita A, et al
    Longitudinal trends in the prevalence of detectable HIV viremia: Population-based evidence from rural KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2017 Nov 25. pii: 4662847. doi: 10.1093.
    >> Share

  111. MOORE DJ, Jain S, Dube MP, Daar ES, et al
    Randomized Controlled Trial of Daily Text Messages To Support Adherence to PrEP In At-Risk for HIV Individuals: The TAPIR Study.
    Clin Infect Dis. 2017 Nov 24. pii: 4656156. doi: 10.1093/cid/cix1055.
    >> Share

  112. BOEREKAMPS A, Newsum AM, Smit C, Arends JE, et al
    High treatment uptake in HIV/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands.
    Clin Infect Dis. 2017 Nov 23. pii: 4654728. doi: 10.1093/cid/cix1004.
    >> Share

  113. ROCKSTROH JK
    Is HCV elimination in well-defined patient groups possible?
    Clin Infect Dis. 2017 Nov 23. pii: 4654730. doi: 10.1093/cid/cix1010.
    >> Share

  114. BOEREKAMPS A, Van den Berk GE, Fanny LN, Leyten EM, et al
    Declining HCV incidence in Dutch HIV positive men who have sex with men after unrestricted access to HCV therapy.
    Clin Infect Dis. 2017 Nov 23. pii: 4654729. doi: 10.1093/cid/cix1007.
    >> Share

  115. JUMARE J, Ndembi N, El-Kamary SS, Magder L, et al
    Cognitive function among antiretroviral treatment-naive individuals infected with HIV-1 Subtype G versus CRF02_AG in Nigeria.
    Clin Infect Dis. 2017 Nov 22. pii: 4647334. doi: 10.1093/cid/cix1019.
    >> Share

  116. SMITH RX, Guha A, Vaida F, Paul RH, et al
    Prefrontal recruitment mitigates risk taking behavior in HIV infected young adults.
    Clin Infect Dis. 2017 Nov 21. pii: 4644866. doi: 10.1093/cid/cix1031.
    >> Share

  117. WONG C, Gange SJ, Moore RD, Justice AC, et al
    Multimorbidity Among Persons Living with HIV in the U.S.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093.
    >> Share

  118. BEDIMO RJ, Adams-Huet B, Poindexter J, Brown G, et al
    The Differential Effects of HIV and HCV on Bone Micro-Architecture and Fracture risk.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1011.
    >> Share

  119. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    >> Share

  120. MCDONALD CR, Conroy AL, Gamble JL, Papp E, et al
    Estradiol Levels Are Altered in Human Immunodeficiency Virus-Infected Pregnant Women Randomized to Efavirenz-Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy.
    Clin Infect Dis. 2017 Nov 10. doi: 10.1093.
    >> Share

  121. MAHESWARAN H, Clarke A, MacPherson P, Kumwenda F, et al
    Cost-effectiveness of community-based HIV self-testing in Blantyre, Malawi.
    Clin Infect Dis. 2017 Nov 9. doi: 10.1093.
    >> Share

  122. AOKI A, Sakagami T, Yoshizawa K, Shima K, et al
    Clinical significance of interferon-gamma neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease.
    Clin Infect Dis. 2017 Nov 8. doi: 10.1093.
    >> Share

  123. GIANELLA S, Haw JS, Blumenthal J, Sullivan B, et al
    The Importance of HIV Research for Transgender and Gender Non-Binary Individuals.
    Clin Infect Dis. 2017 Nov 8. doi: 10.1093.
    >> Share

  124. GRIESEL R, Stewart A, van der Plas H, Sikhondze W, et al
    Optimizing Tuberculosis Diagnosis in HIV-Infected Inpatients Meeting the Criteria of Seriously Ill in the WHO Algorithm.
    Clin Infect Dis. 2017 Nov 6. doi: 10.1093.
    >> Share

  125. SCOTT N, Stoove M, Kelly SL, Wilson DP, et al
    Achieving 90-90-90 HIV targets will not be enough to achieve the HIV incidence reduction target in Australia.
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    >> Share

  126. SCHEER S, Hsu L, Schwarcz S, Pipkin S, et al
    Trends in the San Francisco HIV Epidemic in the "Getting to Zero" Era.
    Clin Infect Dis. 2017 Nov 1. doi: 10.1093.
    >> Share

    October 2017
  127. BRUCE RD, Merlin J, Lum PJ, Ahmed E, et al
    2017 HIV Medicine Association of Infectious Diseases Society of America Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2017;65:1601-1606.
    >> Share

  128. DE LEDINGHEN V, Laforest C, Hezode C, Pol S, et al
    Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    >> Share

  129. BALAJI AB, An Q, Smith JC, Newcomb ME, et al
    High HIV incidence and prevalence and associated factors among adolescent sexual minority males, 3 cities, 2015.
    Clin Infect Dis. 2017 Oct 24. doi: 10.1093.
    >> Share

  130. YAYA I, Costa M, Marcellin F, Miailhes P, et al
    Gender, alcohol use and fibrosis in HIV-HCV co-infected individuals.
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    >> Share

  131. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Reply to van de Wijer et. al.
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    >> Share

  132. ZHAO Y, Wu Z, McGoogan JM, Shi CX, et al
    Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: a nationwide, retrospective cohort study.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    >> Share

  133. HUAMAN MA, Ticona E, Miranda G, Kryscio RJ, et al
    The Relationship between Latent Tuberculosis Infection and Acute Myocardial Infarction.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    >> Share

  134. PARR JB, Lodge EK, Holzmayer V, Pepin J, et al
    An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.
    Clin Infect Dis. 2017 Oct 18. doi: 10.1093.
    >> Share

  135. OSMAN M, Lee K, Du Preez K, Dunbar R, et al
    Excellent Treatment Outcomes in Children Treated for Tuberculosis Under Routine Operational Conditions in Cape Town, South Africa.
    Clin Infect Dis. 2017;65:1444-1452.
    >> Share

  136. AKILIMALI NA, Chang CC, Muema DM, Reddy T, et al
    Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
    Clin Infect Dis. 2017;65:1551-1559.
    >> Share

  137. WANG L, Min JE, Zang X, Sereda P, et al
    Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.
    Clin Infect Dis. 2017;65:1496-1503.
    >> Share

  138. HO A, Aston SJ, Jary H, Mitchell T, et al
    Impact of HIV on the burden and severity of influenza illness in Malawian adults: a prospective cohort and parallel case-control study.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    >> Share

  139. BARBEE LA, Soge OO, Katz DA, Dombrowski JC, et al
    Increases in Neisseria gonorrhoeae with Reduced Susceptibility to Azithromycin among Men who have sex with Men (MSM), in Seattle, King County, Washington: 2012 - 2016.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    >> Share

  140. KENYON C
    Increases in asymptomatic early syphilis may be due to increases in repeat syphilis and not enhanced screening.
    Clin Infect Dis. 2017 Oct 16. doi: 10.1093.
    >> Share

  141. COOKSON ST, Maloney SA
    Keeping Up With a World in Motion: Screening Strategies for Migrating Populations.
    Clin Infect Dis. 2017;65:1410-1411.
    >> Share

  142. ADU-GYAMFI CG, Snyman T, Hoffmann CJ, Martinson NA, et al
    Plasma Indoleamine 2, 3-Dioxygenase, a Biomarker for Tuberculosis in Human Immunodeficiency Virus-Infected Patients.
    Clin Infect Dis. 2017;65:1356-1358.
    >> Share

  143. MEHTA SR, Chaillon A, Gaines TL, Gonzalez-Zuniga PE, et al
    Impact of Public Safety Policies on HIV Transmission Dynamics in Tijuana, Mexico.
    Clin Infect Dis. 2017 Oct 13. doi: 10.1093.
    >> Share

  144. SMIT M, van Zoest RA, Nichols BE, Vaartjes I, et al
    Cardiovascular disease prevention policy in HIV: recommendations from a modelling study.
    Clin Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  145. TAO G, Hoover KW, Nye MB, Peters PJ, et al
    Infrequent testing of women for rectal chlamydia and gonorrhea in the United States.
    Clin Infect Dis. 2017 Oct 6. doi: 10.1093.
    >> Share

  146. WAKE RM, Britz E, Sriruttan C, Rukasha I, et al
    High Cryptococcal Antigen Titers in Blood are Predictive of Subclinical Cryptococcal Meningitis Among HIV-Infected Patients.
    Clin Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  147. BRAUN DL, Marzel A, Steffens D, Schreiber PW, et al
    High rates of subsequent asymptomatic STIs and risky sexual behavior in patients initially presenting with primary HIV-1 infection.
    Clin Infect Dis. 2017 Oct 5. doi: 10.1093.
    >> Share

  148. GEORGE IA, Spec A, Powderly WG, Santos CAQ, et al
    Comparative Epidemiology and Outcomes of HIV, Non-HIV Non-Transplant and Organ Transplant Associated Cryptococcosis: A Population-Based Study.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

  149. PASQUIER E, Kunda J, De Beaudrap P, Loyse A, et al
    Long term mortality and disability in Cryptococcal Meningitis: a systematic literature review.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    >> Share

    September 2017
  150. COLLINS IJ
    Time to switch to second-line antiretroviral therapy in children with HIV in Europe and Thailand.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  151. THAO LTP, Heemskerk AD, Geskus RB, Mai NTH, et al
    Prognostic models for 9 month mortality in tuberculous meningitis.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  152. DIONNE-ODOM J, Geisler WM, Aaron KJ, Waites KB, et al
    High Prevalence of Multidrug-Resistant Mycoplasma genitalium in HIV-infected Men who have Sex with Men in Alabama.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  153. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  154. SALAZAR-AUSTIN N, Hoffmann J, Cohn S, Mashabela F, et al
    Poor Obstetric and Infant Outcomes in HIV-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  155. NOSYK B, Min JE, Krebs E, Zang X, et al
    The cost-effectiveness of HIV testing and treatment engagement initiatives in British Columbia, Canada: 2011-2013.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    >> Share

  156. MACIAS J, Mancebo M, Merino D, Tellez F, et al
    Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus-Infected Patients With Nonalcoholic Fatty Liver Disease.
    Clin Infect Dis. 2017;65:1012-1019.
    >> Share

  157. TRICKEY A, May MT, Schommers P, Tate J, et al
    CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Clin Infect Dis. 2017;65:959-966.
    >> Share

  158. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    >> Share

  159. BRUCE RD, Merlin J, Lum PJ, Ahmed E, et al
    2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.
    Clin Infect Dis. 2017 Sep 14. doi: 10.1093.
    >> Share

  160. HUGHES AJ, Scheer S
    Evidence of STD testing outside of primary HIV care for people living with HIV in San Francisco, California.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    >> Share

  161. DIRO E, Ritmeijer K, Boelaert M, Alves F, et al
    Long-term clinical outcomes in visceral leishmaniasis-HIV co-infected patients during and after pentamidine secondary prophylaxis in Ethiopia: a single-arm clinical trial Authors and affiliations.
    Clin Infect Dis. 2017 Sep 13. doi: 10.1093.
    >> Share

  162. ASSOUMOU SA, Tasillo A, Leff JA, Schackman BR, et al
    The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.
    Clin Infect Dis. 2017 Sep 9. doi: 10.1093.
    >> Share

  163. DAVIS AP, Stern J, Tantalo L, Sahi S, et al
    How well do neurologic symptoms identify individuals with neurosyphilis?
    Clin Infect Dis. 2017 Sep 9. doi: 10.1093.
    >> Share

  164. VAN DUIN D, Lok JJ, Earley M, Cober E, et al
    Colistin vs. Ceftazidime-avibactam in the Treatment of Infections due to Carbapenem-Resistant Enterobacteriaceae.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    >> Share

  165. DESAI SR, Nair A, Rylance J, Mujuru H, et al
    HIV-Associated Chronic Lung Disease in Children and Adolescents in Zimbabwe: Chest Radiographic and High-Resolution Computed Tomography Findings.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    >> Share

  166. SIVRO A, McKinnon LR, Yende-Zuma N, Gengiah S, et al
    Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa.
    Clin Infect Dis. 2017;65:819-826.
    >> Share

    August 2017
  167. MODY A, Roy M, Sikombe K, Savory T, et al
    Improved Retention with Six Month Clinic Return Intervals for Stable HIV-Infected Patients in Zambia.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    >> Share

  168. BALOGUN KA, Lenis MG, Papp E, Loutfy M, et al
    Elevated levels of estradiol in HIV-positive pregnant women on protease inhibitor-based regimens.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    >> Share

  169. ESMAEILI A, Mirzazadeh A, Morris MD, Hajarizadeh B, et al
    The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    >> Share

  170. KOSS CA, Hosek SG, Bacchetti P, Anderson PL, et al
    Comparison of Measures of Adherence to HIV Preexposure Prophylaxis among Adolescent and Young Men Who Have Sex with Men in the United States.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    >> Share

  171. HAVENS PL, Stephensen CB, Van Loan MD, Schuster GU, et al
    Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults with HIV Infection Being Treated with Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2017 Aug 21. doi: 10.1093.
    >> Share

  172. KOUAME GM, Boyd A, Moh R, Badje A, et al
    Higher mortality despite early ART in HIV and hepatitis B virus coinfected patients with high HBV replication.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    >> Share

  173. WANG H, Wan Z, Xu R, Guan Y, et al
    A Novel Human Pegivirus HPgV-2 (HHpgV-1) is Tightly Associated with HCV Infection and HCV/HIV-1 Co-Infection.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    >> Share

  174. PULIDO F, Ribera E, Lagarde M, Perez-Valero I, et al
    Dual therapy with darunavir and ritonavir plus lamivudine versus triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and lamivudine for maintenance of HIV-1 viral suppression: randomised, open l
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    >> Share

  175. MORIN S, Bazarova N, Jacon P, Vella S, et al
    The manufacturers' perspective on WHO Prequalification of In Vitro Diagnostics.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    >> Share

  176. KELLY EM, Dodge JL, Bacchetti P, Sarkar M, et al
    Moderate Alcohol use is not Associated with Fibrosis Progression in HIV/HCV Co-Infected Women: A Prospective Cohort Study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    >> Share

  177. LO RE V 3RD
    Is Moderate Alcohol Consumption Safe for HIV/Hepatitis C Virus-Coinfected Women?
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    >> Share

  178. BYRNE DD, Tate JP, Forde KA, Lim JK, et al
    Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    >> Share

  179. PARASKEVIS D, Kostaki E, Nikolopoulos GK, Sypsa V, et al
    Molecular tracing of the geographical origin of HIV-1 infection and patterns of epidemic spread among migrants who inject drugs in Athens.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    >> Share

  180. ENGELS EA, Yanik EL, Wheeler W, Gill MJ, et al
    Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America.
    Clin Infect Dis. 2017;65:636-643.
    >> Share

  181. VAN DUIN D, Bonomo RA
    Reply to Macesic et al.
    Clin Infect Dis. 2017;65:703-704.
    >> Share

  182. HAKRE S, Casimier RO, Danboise BA, Peel SA, et al
    Enhanced Sexually Transmitted Infection Screening for Mycoplasma genitalium in Human Immunodeficiency Virus -Infected US Air Force Personnel.
    Clin Infect Dis. 2017 Aug 9. doi: 10.1093.
    >> Share

  183. JORDAN MR, Penazzato M, Cournil A, Vubil A, et al
    HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis.
    Clin Infect Dis. 2017 Aug 8. doi: 10.1093.
    >> Share

    July 2017
  184. MARCUS JL, Hurley LB, Nguyen DP, Silverberg MJ, et al
    Redefining HIV Preexposure Prophylaxis Failures.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    >> Share

  185. SALINAS JL, Armstrong LR, Silk BJ, Haddad MB, et al
    Factors Associated with All-Cause Mortality among Patients with Multidrug-Resistant Tuberculosis - United States, 1993-2013.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    >> Share

  186. ERLANDSON KM, Kitch D, Wester WC, Kalayjian RC, et al
    The Impact of Statin and ACE-inhibitor/Angiotensin Receptor Blocker Therapy on Cognitive Function in Adults with HIV Infection.
    Clin Infect Dis. 2017 Jul 27. doi: 10.1093.
    >> Share

  187. SARKAR M, Dodge JL, Greenblatt RM, Kuniholm MH, et al
    Reproductive Aging and Hepatic Fibrosis Progression in HIV/Hepatitis C Virus Co-Infected Women.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    >> Share

  188. FLORIDIA M, Ciccacci F, Andreotti M, Hassane A, et al
    Tuberculosis case finding with combined rapid point of care assays (Xpert(R) MTB/RIF and LAM) in HIV-positive individuals starting antiretroviral treatment in Mozambique.
    Clin Infect Dis. 2017 Jul 23. doi: 10.1093.
    >> Share

  189. ABONGOMERA C, Diro E, Vogt F, Tsoumanis A, et al
    The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    >> Share

  190. PASTOR L, Casellas A, Ruperez M, Carrillo J, et al
    Interferon-gamma-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings.
    Clin Infect Dis. 2017 Jul 19. doi: 10.1093.
    >> Share

  191. BEYENE T, Zewde AG, Balcha A, Hirpo B, et al
    High Dose Fluconazole Monotherapy is Inadequate for CSF Cryptococcal Antigen Positive HIV-infected Persons in an Ethiopian CrAg Screening Program.
    Clin Infect Dis. 2017 Jul 17. doi: 10.1093.
    >> Share

  192. OLIVER SE, Cope AB, Rinsky JL, Williams C, et al
    Increases in Ocular Syphilis-North Carolina, 2014-2015.
    Clin Infect Dis. 2017 Jul 13. doi: 10.1093.
    >> Share

  193. SERPA JA, Rueda AM, Somasunderam A, Utay NS, et al
    Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
    Clin Infect Dis. 2017 Jul 7. doi: 10.1093.
    >> Share

    June 2017
  194. KATZ MJ, Gurses AP, Tamma PD, Cosgrove SE, et al
    Implementing Antimicrobial Stewardship in Long-term Care Settings: An Integrative Review Using a Human Factors Approach.
    Clin Infect Dis. 2017 Jun 20. doi: 10.1093.
    >> Share

  195. SMITH SE, Pratt R, Trieu L, Barry PM, et al
    Epidemiology of pediatric multidrug-resistant tuberculosis in the United States, 1993-2014.
    Clin Infect Dis. 2017 Jun 19. doi: 10.1093.
    >> Share

  196. HIGDON MM, Le T, O'Brien KL, Murdoch DR, et al
    Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study.
    Clin Infect Dis. 2017;64.
    >> Share

  197. PARK DE, Baggett HC, Howie SRC, Shi Q, et al
    Colonization Density of the Upper Respiratory Tract as a Predictor of Pneumonia-Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii.
    Clin Infect Dis. 2017;64.
    >> Share

  198. LOSINA E, Hyle EP, Borre ED, Linas BP, et al
    Projecting 10-yr, 20-yr and Lifetime Risks of Cardiovascular Disease in Persons Living with HIV in the US.
    Clin Infect Dis. 2017 Jun 12. doi: 10.1093.
    >> Share

  199. KOULLIAS Y, Sax PE, Fields NF, Walensky RP, et al
    Should we be testing for baseline integrase resistance in patients newly diagnosed with HIV?
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    >> Share

  200. MCCOLLUM ED, Ginsburg AS
    Outpatient Management of Children With World Health Organization Chest Indrawing Pneumonia: Implementation Risks and Proposed Solutions.
    Clin Infect Dis. 2017 Jun 9. doi: 10.1093.
    >> Share

  201. SCHALKWIJK S, Colbers A, Konopnicki D, Gingelmaier A, et al
    Lowered rilpivirine exposure during third trimester of pregnancy in HIV-1-positive women.
    Clin Infect Dis. 2017 Jun 8. doi: 10.1093.
    >> Share

  202. NEL JS, Lippincott CK, Berhanu R, Spencer DC, et al
    Does disseminated nontuberculous mycobacterial disease cause false-positive Determine B-LAM lateral flow assay results? A retrospective review.
    Clin Infect Dis. 2017 Jun 2. doi: 10.1093.
    >> Share

  203. PENAZZATO M, Gnanashanmugam D, Rojo P, Lallemant M, et al
    Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations.
    Clin Infect Dis. 2017;64:1597-1603.
    >> Share

    May 2017
  204. SANDUL AL, Nwana N, Holcombe JM, Lobato MN, et al
    High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    >> Share

  205. JAO J, Kacanek D, Williams PL, Geffner ME, et al
    Birth Weight and Preterm Delivery Outcomes of Perinatally vs. non-Perinatally HIV-infected Pregnant Women in the U.S.: Results from the PHACS SMARTT Study and IMPAACT P1025 Protocol.
    Clin Infect Dis. 2017 May 30. doi: 10.1093.
    >> Share

  206. FEARNHILL E, Gourlay A, Malyuta R, Simmons R, et al
    A Phylogenetic Analysis of HIV-1 Sequences in Kiev: Findings among Key Populations.
    Clin Infect Dis. 2017 May 29. doi: 10.1093.
    >> Share

  207. BRINKLEY-RUBINSTEIN L, Rosen DL, Christopher P, Bazerman L, et al
    Long Acting Injectable Anti-Retroviral Therapy: An Opportunity to Improve HIV Treatment and Reduce HIV Transmission among Persons being Released from Prison Facilities.
    Clin Infect Dis. 2017 May 26. doi: 10.1093.
    >> Share

  208. KUNIHOLM MH, Strickler HD, Anastos K, Prokunina-Olsson L, et al
    Relationship of Genotype for HLA B*57 and IFNL4 with Disease Progression in Female HIV Controllers.
    Clin Infect Dis. 2017 May 24. doi: 10.1093.
    >> Share

  209. PRODGER JL, Lai J, Reynolds SJ, Keruly JC, et al
    Reduced Frequency of Cells Latently Infected with Replication-Competent HIV-1 in Virally Suppressed Individuals Living in Rakai, Uganda.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    >> Share

  210. AIBANA O, Franke MF, Huang CC, Galea JT, et al
    Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    >> Share

  211. BOHLIUS J
    Comparison of Kaposi sarcoma risk in HIV-positive adults across five continents: a multiregional multicohort study.
    Clin Infect Dis. 2017 May 20. doi: 10.1093.
    >> Share

  212. HO EL, Maxwell CL, Dunaway SB, Sahi SK, et al
    Neurosyphilis Increases HIV-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals with Syphilis.
    Clin Infect Dis. 2017 May 19. doi: 10.1093.
    >> Share

  213. KAWKITINARONG K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, et al
    Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Clin Infect Dis. 2017;64.
    >> Share

  214. TENFORDE MW, Mokomane M, Leeme T, Patel RKK, et al
    Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    >> Share

  215. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Incidence of Gonorrhea and Chlamydia Following HIV Preexposure Prophylaxis among Men Who Have Sex with Men: A Modeling Study.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    >> Share

  216. FOLARANMI TA, Kretz CB, Kamiya H, MacNeil JR, et al
    Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    >> Share

  217. COLE SR, Edwards JK, Hall HI, Brookhart MA, et al
    Incident AIDS or Death After Initiation of Human Immunodeficiency Virus Treatment Regimens Including Raltegravir or Efavirenz Among Adults in the United States.
    Clin Infect Dis. 2017 May 12. doi: 10.1093.
    >> Share

  218. BAZAN JA, Turner AN, Kirkcaldy RD, Retchless AC, et al
    Large Cluster of Neisseria Meningitidis Urethritis in Columbus, Ohio, 2015.
    Clin Infect Dis. 2017 May 8. doi: 10.1093.
    >> Share

  219. HARAUSZ EP, Leigh J, Garcia-Prats AJ, Furin J, et al
    Stability of Second-Line Tuberculosis Medications Mixed with Milk or Yogurt.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    >> Share

  220. SOCIAS ME, Nosova E, Kerr T, Hayashi K, et al
    Patterns of transmitted drug resistance and virological response to first-line antiretroviral treatment among HIV-positive people who use illicit drugs in a Canadian setting.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    >> Share

  221. BARDENHEIER BH, McNeil MM, Wodi AP, McNicholl J, et al
    Risk of non-targeted infectious disease hospitalizations among U.S. children following inactivated and live vaccines, 2005-2014.
    Clin Infect Dis. 2017 May 6. doi: 10.1093.
    >> Share

  222. SEIFERT M, Georghiou SB, Garfein RS, Catanzaro D, et al
    Impact of fluoroquinolone use on mortality among a cohort of suspected drug-resistant tuberculosis patients.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    >> Share

  223. WALKER NF, Wilkinson KA, Meintjes G, Tezera LB, et al
    Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study.
    Clin Infect Dis. 2017 May 5. doi: 10.1093.
    >> Share

    April 2017
  224. ROSENBERG ES, Hall EW, Sullivan PS, Sanchez TH, et al
    Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Clin Infect Dis. 2017 Apr 26. doi: 10.1093.
    >> Share

  225. DIEPSTRA KL, Rhodes AG, Bono RS, Patel S, et al
    Comprehensive Ryan White Assistance and HIV Clinical Outcomes: Retention in Care and Viral Suppression in a Medicaid Non-Expansion State.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    >> Share

  226. LORENZ DR, Dutta A, Mukerji SS, Holman A, et al
    Marijuana use impacts midlife cardiovascular events in HIV-infected men.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    >> Share

  227. GUTIERREZ-VALENCIA A, Benmarzouk-Hidalgo OJ, Rivas-Jeremias I, Espinosa N, et al
    Viral kinetics in semen with different antiretroviral families in treatment-naive HIV-infected patients: a randomized trial.
    Clin Infect Dis. 2017 Apr 25. doi: 10.1093.
    >> Share

  228. EATON JW, Johnson CC, Gregson S
    The cost of not re-testing: HIV misdiagnosis in the ART 'test-and-offer' era.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    >> Share

  229. LAZAR R, Kersanske L, Xia Q, Daskalakis D, et al
    Hospitalization rates among people with HIV/AIDS in New York City, 2013.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    >> Share

  230. DAVIS NL, Wiener J, Juliano JJ, Adair L, et al
    Co-trimoxazole prophylaxis, asymptomatic malaria parasitemia, and infectious morbidity in HIV-exposed uninfected infants in Malawi: The BAN study.
    Clin Infect Dis. 2017 Apr 21. doi: 10.1093.
    >> Share

  231. MURNANE PM, Strehlau R, Shiau S, Patel F, et al
    Switching to efavirenz versus remaining on ritonavir-boosted lopinavir in HIV-infected children exposed to nevirapine: long-term outcomes of a randomized trial.
    Clin Infect Dis. 2017 Apr 17. doi: 10.1093.
    >> Share

  232. EATON EF, Gravett RM, Tamhane AR, Mugavero MJ, et al
    Antiretroviral Therapy Initiation and Changes in Self-Reported Depression.
    Clin Infect Dis. 2017 Apr 15. doi: 10.1093.
    >> Share

  233. CHOW EPF, Callander D, Fairley CK, Zhang L, et al
    Increased syphilis testing of men who have sex with men: greater detection of asymptomatic early syphilis and relative reduction in secondary syphilis.
    Clin Infect Dis. 2017 Apr 13. doi: 10.1093.
    >> Share

  234. GUARALDI G, Rockwood K
    Geriatric-HIV medicine is born.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  235. UNDERWOOD J, Cole JH, Caan M, De Francesco D, et al
    Grey and white matter abnormalities in treated HIV-disease and their relationship to cognitive function.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  236. WALENSKY RP, Del Rio C, Armstrong WS
    Charting the Future of Infectious Disease: Anticipating and Addressing the Supply and Demand Mismatch.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  237. SINGH HK, Del Carmen T, Freeman R, Glesby MJ, et al
    From One Syndrome to Many: Incorporating Geriatric Consultation into HIV Care.
    Clin Infect Dis. 2017 Apr 6. doi: 10.1093.
    >> Share

  238. ADAORA A A, Cole SR, Eron JJ
    US Black Women and HIV Prevention: Time for New Approaches to Clinical Trials.
    Clin Infect Dis. 2017 Apr 5. doi: 10.1093.
    >> Share

  239. QIN Q, Guo W, Tang W, Mahapatra T, et al
    Spatial Analysis of the Human Immunodeficiency Virus Epidemic among Men Who Have Sex with Men in China, 2006-2015.
    Clin Infect Dis. 2017;64:956-963.
    >> Share

  240. MORRIS MD, Shiboski S, Bruneau J, Hahn JA, et al
    Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
    Clin Infect Dis. 2017;64:860-869.
    >> Share

  241. SUNGKANUPARPH S, Savetamornkul C, Pattanapongpaiboon W
    Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/microL and Receiving Antiretroviral Therapy.
    Clin Infect Dis. 2017;64:967-970.
    >> Share

  242. BROGER T, Basu Roy R, Filomena A, Greef CH, et al
    Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.
    Clin Infect Dis. 2017;64:947-955.
    >> Share

  243. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    >> Share

    March 2017
  244. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    >> Share

  245. JOHS NA, Wu K, Tassiopoulos K, Koletar SL, et al
    Disability among Middle-Aged and Older Persons with HIV Infection.
    Clin Infect Dis. 2017 Mar 27. doi: 10.1093.
    >> Share

  246. SOHN AH, Hazra R
    Old Problems for New Providers: Managing the Postpediatric HIV Generation.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    >> Share

  247. JANSSEN S, Schutz C, Ward A, Nemes E, et al
    Mortality in Severe HIV-TB Associates with Innate Immune Activation and Dysfunction of Monocytes.
    Clin Infect Dis. 2017 Mar 24. doi: 10.1093.
    >> Share

  248. BECOFSKY K, Wing EJ, McCaffery J, Bodreau M, et al
    A Randomized, Controlled Trial of a Behavioral Weight Loss Program for HIV-Infected Patients.
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    >> Share

  249. HWANG C, Schurmann D, Sobotha C, Boffito M, et al
    Antiviral Activity, Safety, and Exposure-Response relationships of GSK3532795, a Second-Generation HIV-1 Maturation Inhibitor, administered as Monotherapy or in Combination with Atazanavir+/-Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled
    Clin Infect Dis. 2017 Mar 23. doi: 10.1093.
    >> Share

  250. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    >> Share

  251. ADACHI K, Xu J, Ank B, Watts DH, et al
    Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    >> Share

  252. MADHI SA, Nunes M, Weinberg A, Kuwanda L, et al
    Contribution of serology assays in the evaluation of influenza virus infection rates and vaccine efficacy in pregnant women: Report from randomized controlled trials.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    >> Share

  253. THOMAS M, Hopkins C, Duffy E, Lee D, et al
    Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.
    Clin Infect Dis. 2017 Mar 21. doi: 10.1093.
    >> Share

  254. CURLIN ME, Gvetadze R, Leelawiwat W, Martin M, et al
    Analysis of false-negative HIV rapid tests performed on oral fluid in three international clinical research studies.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    >> Share

  255. GOURLAY A, Noori T, Pharris A, Axelsson M, et al
    The HIV continuum of care in European Union countries in 2013: data and challenges.
    Clin Infect Dis. 2017 Mar 20. doi: 10.1093.
    >> Share

  256. BERSHETYN A, Odeny TA, Lyamuya R, Nakiwogga-Muwanga A, et al
    The causal effect of tracing by peer health workers on return to clinic among patients who were lost to follow-up from antiretroviral therapy in eastern Africa: a randomized "natural experiment" arising from surveillance of lost patients.
    Clin Infect Dis. 2017 Mar 17. doi: 10.1093.
    >> Share

  257. WHITE AC JR
    Treatment of Early Syphilis in HIV: What Do We Really Know?
    Clin Infect Dis. 2017;64:765-766.
    >> Share

  258. COLLIER D, Iwuji C, Derache A, de Oliveira T, et al
    Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    >> Share

  259. HERRICK JA, Legrand F, Gounoue R, Nchinda G, et al
    Posttreatment Reactions After Single-Dose Diethylcarbamazine or Ivermectin in Subjects With Loa loa Infection.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    >> Share

  260. KUGATHASAN R, Collier DA, Haddow LJ, El Bouzidi K, et al
    Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms.
    Clin Infect Dis. 2017 Mar 13. doi: 10.1093.
    >> Share

  261. CEPEDA JA, Thomas DL, Astemborski J, Sulkowski MS, et al
    Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    >> Share

  262. HOFSTRA LM, Sanchez Rivas E, Nijhuis M, Bank LE, et al
    High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  263. CYKTOR JC, Mellors JW
    TLR Agonists: Can They Exact a Toll on HIV Persistence?
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  264. VIBHOLM L, Schleimann MH, Hojen JF, Benfield T, et al
    Short-course TLR9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals with HIV infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  265. COLLINS IJ, Foster C, Tostevin A, Tookey P, et al
    Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  266. UPRETY P, Patel K, Karalius B, Ziemniak C, et al
    HIV-1 DNA Decay Dynamics with Early, Long-term Virologic Control of Perinatal Infection.
    Clin Infect Dis. 2017 Mar 9. doi: 10.1093.
    >> Share

  267. PARKER RA, Rabideau DJ, Sax PE, Tierney C, et al
    The Impact of Medication Adherence on Virologic Failure in A5202, A Randomized, Partially-Blinded, Phase 3B Study.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    >> Share

  268. NEGOESCU DM, Zhang Z, Bucher HC, Bendavid E, et al
    Differentiated HIV Rna Viral Load Monitoring in Resource Limited Settings: An Economic Analysis.
    Clin Infect Dis. 2017 Mar 1. doi: 10.1093.
    >> Share

    February 2017
  269. NAGGIE S, Marks KM, Hughes M, Fierer DS, et al
    Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
    Clin Infect Dis. 2017 Feb 27. doi: 10.1093.
    >> Share

  270. LAKE JE, Stanley T, Apovian C, Bhasin S, et al
    Practical Review of Recognition and Management of Obesity and Lipohypertrophy in HIV Infection.
    Clin Infect Dis. 2017 Feb 24. doi: 10.1093.
    >> Share

  271. BORGES AH, Hoy J, Florence E, Sedlacek D, et al
    Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort.
    Clin Infect Dis. 2017 Feb 22. doi: 10.1093.
    >> Share

  272. ELUL B, Saito S, Chung H, Hoos D, et al
    Attrition from HIV treatment programs in Africa: A longitudinal ecological analysis using data from 307,144 patients initiating antiretroviral therapy between 2005 and 2010.
    Clin Infect Dis. 2017 Feb 21. doi: 10.1093.
    >> Share

  273. RAVIMOHAN S, Tamuhla N, Nfanyana K, Ni H, et al
    Elevated pre-ART CD39+CD8+ T-cell frequency is associated with early mortality in advanced HIV/TB.
    Clin Infect Dis. 2017 Feb 16. doi: 10.1093.
    >> Share

  274. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2017;64:527-528.
    >> Share

  275. MORRIS SR, Zhao M, Smith DM, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2017;64:428-434.
    >> Share

  276. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.
    Clin Infect Dis. 2017;64:459-467.
    >> Share

  277. LO RE V
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2017;64:498-500.
    >> Share

  278. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C Infection and the Risk of Non-Liver-Related Morbidity and Mortality in HIV-Infected Persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017;64:490-497.
    >> Share

  279. ANDRADE R, Rodriguez-Barradas MC, Yasukawa K, Villarreal E, et al
    Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.
    Clin Infect Dis. 2017 Feb 14. doi: 10.1093.
    >> Share

  280. FONJUNGO PN, Alemnji GA, Kebede Y, Opio A, et al
    Combatting Global Infectious Diseases: A Network Effect of Specimen Referral Systems.
    Clin Infect Dis. 2017 Feb 13. doi: 10.1093.
    >> Share

  281. CLIFFORD GM, Tully S, Franceschi S
    Carcinogenicity of human papillomavirus types in HIV-positive women: A meta-analysis from HPV infection to cervical cancer.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    >> Share

  282. YOUNG J, Rossi C, Gill J, Walmsley S, et al
    Risk factors for hepatitis C virus reinfection after sustained virologic response in patients co-infected with HIV.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    >> Share

  283. BHATTACHARYA D, Belperio PS, Shahoumian TA, Loomis TP, et al
    Effectiveness of All-Oral Antiviral Regimens in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  284. BURTON MJ, Naggie S
    Real World Effectiveness of DAA Therapies in HIV/HCV Co-Infection: 996 Veterans Can't Be Wrong.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  285. BEGUELIN C, Friolet N, Moradpour D, Sahli R, et al
    Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  286. BAGHI HB, Aghazadeh M, Rashedi J, Poor BM, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    >> Share

  287. ANDREONI M, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  288. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllers.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  289. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin-18 in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Coinfection Versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  290. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal Infection in Patients Without HIV.
    Clin Infect Dis. 2017 Feb 9. doi: 10.1093.
    >> Share

  291. FERRANDO-MARTINEZ S, De Pablo-Bernal RS, De Luna-Romero M, De Ory SJ, et al
    Thymic function failure is associated with HIV-disease progression.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    >> Share

  292. VINIKOOR MJ, Sinkala E, Chilengi R, Mulenga L, et al
    Impact of antiretroviral therapy on liver fibrosis among HIV-infected adults with and without HBV coinfection in Zambia.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    >> Share

  293. DUGAST AS, Arnold K, Lofano G, Moore S, et al
    Virus-driven inflammation is associated with the development of bNAbs in spontaneous controllers of HIV.
    Clin Infect Dis. 2017 Feb 3. doi: 10.1093.
    >> Share

    January 2017
  294. PROANO A, Bravard MA, Lopez JW, Lee GO, et al
    Dynamics of Cough Frequency in Adults Undergoing Treatment for Pulmonary Tuberculosis.
    Clin Infect Dis. 2017 Jan 25. doi: 10.1093.
    >> Share

  295. EL-MALLAWANY NK, Villiera J, Kamiyango W, Mhango J, et al
    Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi.
    Clin Infect Dis. 2017 Jan 11. pii: ciw879. doi: 10.1093.
    >> Share

  296. RIVERO-JUAREZ A, Frias M, Lopez-Lopez P, Risalde ML, et al
    Hepatitis E virus infection in anti-HEV IgG-carryinfing patients after successful HCV treatment: reactivation or reinfection?
    Clin Infect Dis. 2017 Jan 11. pii: cix004. doi: 10.1093.
    >> Share

  297. BANNAZADEH BAGHI H, Aghazadeh M, Rashedi J, Mahdavi Poor B, et al
    HIV/AIDS in Iran.
    Clin Infect Dis. 2017 Jan 11. pii: cix006. doi: 10.1093.
    >> Share

    December 2016
  298. SORIA A, Alteri C, Scarlatti G, Bertoli A, et al
    Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report.
    Clin Infect Dis. 2016 Dec 28. pii: ciw851. doi: 10.1093.
    >> Share

  299. PINTYE J, Drake AL, Kinuthia J, Unger JA, et al
    A risk assessment tool for identifying pregnant and postpartum women who may benefit from pre-exposure prophylaxis (PrEP).
    Clin Infect Dis. 2016 Dec 28. pii: ciw850. doi: 10.1093.
    >> Share

  300. LIN A, Ong KJ, Hobbelen P, King E, et al
    Impact and cost-effectiveness of selective human papillomavirus vaccination of men who have sex with men.
    Clin Infect Dis. 2016 Dec 23. pii: ciw845. doi: 10.1093.
    >> Share

  301. PATEL EU, Kirkpatrick AR, Grabowski MK, Kigozi G, et al
    Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.
    Clin Infect Dis. 2016 Dec 22. pii: ciw847. doi: 10.1093.
    >> Share

  302. MASSIMO A, Teti E, Antinori A, Milazzoi L, et al
    Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
    Clin Infect Dis. 2016 Dec 22. pii: ciw846. doi: 10.1093.
    >> Share

  303. DOMINGUEZ-MOLINA B, Tarancon-Diez L, Hua S, Abad-Molina C, et al
    HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
    Clin Infect Dis. 2016.
    >> Share

  304. CRANSTON RD, Lama JR, Richardson BA, Carballo-Dieguez A, et al
    MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
    Clin Infect Dis. 2016.
    >> Share

  305. LO RE V 3RD
    Extrahepatic Complications of Hepatitis C Virus Infection in HIV and the Impact of Successful Antiviral Treatment.
    Clin Infect Dis. 2016.
    >> Share

  306. KOVARI H, Rauch A, Kouyos R, Rougemont M, et al
    Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-positive persons in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2016.
    >> Share

  307. MATTSON CL, Bradley H, Beer L, Johnson C, et al
    Increased STD testing among sexually active persons receiving medical care for HIV infection in the United States, 2009 - 2013.
    Clin Infect Dis. 2016.
    >> Share

  308. ROJAS LJ, Salim M, Cober E, Richter SS, et al
    Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
    Clin Infect Dis. 2016.
    >> Share

  309. WONG C, Gange SJ, Buchacz K, Moore RD, et al
    First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013.
    Clin Infect Dis. 2016.
    >> Share

  310. SHIELS MS, Althoff KN, Pfeiffer RM, Achenbach CJ, et al
    HIV Infection, Immune Suppression and Age at Diagnosis of Non-AIDS-Defining Cancers.
    Clin Infect Dis. 2016.
    >> Share

  311. MAZUR NI, Bont L, Cohen AL, Cohen C, et al
    Severity of Respiratory Syncytial Virus Lower Respiratory Tract Infection with Viral Coinfection in HIV-uninfected Children.
    Clin Infect Dis. 2016.
    >> Share

  312. SPEC A, Olsen MA, Raval K, Powderly WG, et al
    Impact of Infectious Diseases Consultation on Mortality of Cryptococcal infection in Patients without HIV.
    Clin Infect Dis. 2016.
    >> Share

  313. MORRIS SR, Zhao M, Smith DR, Vargas MV, et al
    Longitudinal Viral Dynamics in Semen During Early HIV Infection.
    Clin Infect Dis. 2016.
    >> Share

  314. WALL EC, Mukaka M, Scarborough M, Ajdukiewicz KM, et al
    Prediction of outcome from adult bacterial meningitis in a high HIV seroprevalence, resource-poor setting using the Malawi Adult Meningitis Score (MAMS).
    Clin Infect Dis. 2016.
    >> Share

  315. VEENHUIS RT, Astemborski J, Chattergoon MA, Greenwood P, et al
    Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
    Clin Infect Dis. 2016.
    >> Share

  316. VINNARD C, King L, Munsiff S, Crossa A, et al
    The Long-Term Mortality of Tuberculosis Meningitis Patients in New York City: A Cohort Study.
    Clin Infect Dis. 2016.
    >> Share

  317. MYER L, Dunning L, Lesosky M, Hsiao NY, et al
    Frequency of viremic episodes in HIV-infected women initiating antiretroviral therapy during pregnancy: a cohort study.
    Clin Infect Dis. 2016.
    >> Share

  318. PETERS H, Francis K, Sconza R, Horn A, et al
    UK Mother to Child HIV Transmission Rates Continue to Decline: 2012-2014.
    Clin Infect Dis. 2016.
    >> Share

  319. BARGER-KAMATE B, Deloria Knoll M, Kagucia EW, Prosperi C, et al
    Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study.
    Clin Infect Dis. 2016;63.
    >> Share

  320. NUNES MC, Downs S, Jones S, van Niekerk N, et al
    Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother-Infant Dyads: A Longitudinal Cohort Study.
    Clin Infect Dis. 2016;63.
    >> Share

  321. SOOFIE N, Nunes MC, Kgagudi P, van Niekerk N, et al
    The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants.
    Clin Infect Dis. 2016;63.
    >> Share

  322. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    >> Share

    November 2016
  323. HAVENS PL, Stephensen CB, Van Loan MD, Schuster GU, et al
    Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
    Clin Infect Dis. 2016 Nov 15. pii: ciw765. doi: 10.1093.
    >> Share

  324. MEIJIDE H, Mena A, Rodriguez-Osorio I, Castro-Iglesias A, et al
    Cancer Incidence in Persons Living With HIV.
    Clin Infect Dis. 2016 Nov 14. pii: ciw759. doi: 10.1093.
    >> Share

  325. BADER J, Daumer M, Schoni-Affolter F, Boni J, et al
    Therapeutic immune recovery prevents emergence of CXCR4-tropic HIV-1.
    Clin Infect Dis. 2016.
    >> Share

  326. PANACKAL AA, Komori M, Kosa P, Khan O, et al
    Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults.
    Clin Infect Dis. 2016 Nov 10. pii: ciw739. doi: 10.1093.
    >> Share

  327. GAISA M, Ita-Nagy F, Sigel K, Arens Y, et al
    High Rates of Anal High-Grade Squamous Intraepithelial Lesions in HIV-Infected Women Who Do Not Meet Screening Guidelines.
    Clin Infect Dis. 2016.
    >> Share

  328. FOSTER AL, Gaisa MM, Hijdra RM, Turner SS, et al
    Shedding of Hepatitis C Virus Into the Rectum of HIV-infected Men Who Have Sex With Men.
    Clin Infect Dis. 2016 Nov 9. pii: ciw740. doi: 10.1093.
    >> Share

    October 2016
  329. BHARTI AR, McCutchan A, Deutsch R, Smith DM, et al
    Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.
    Clin Infect Dis. 2016.
    >> Share

  330. PELOQUIN CA, Dorman SE, Vernon A, Battista Migliori G, et al
    Reply to Alffenaar et al.
    Clin Infect Dis. 2016.
    >> Share

  331. HUNT PW
    Very Early ART and Persistent Inflammation in Treated HIV.
    Clin Infect Dis. 2016.
    >> Share

  332. ROSADO-SANCHEZ I, Herrero-Fernandez I, Genebat M, Ruiz-Mateos E, et al
    Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Clin Infect Dis. 2016.
    >> Share

  333. WU H, Mendoza MC, Huang YA, Hayes T, et al
    Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.
    Clin Infect Dis. 2016.
    >> Share

  334. RUSSELL K, Hills SL, Oster AM, Porse CC, et al
    Male-to-Female Sexual Transmission of Zika Virus-United States, January-April 2016.
    Clin Infect Dis. 2016.
    >> Share

  335. SAINZ T, Navarro ML
    HIV-Infected Youths: Transition in Spain Compared to the Netherlands.
    Clin Infect Dis. 2016.
    >> Share

  336. GOLDSCHMIDT RH
    Preexposure Prophylaxis in the United States: An Evolving HIV Prevention Opportunity.
    Clin Infect Dis. 2016.
    >> Share

  337. DELANEY KP, Hanson DL, Masciotra S, Ethridge SF, et al
    Time until emergence of HIV test reactivity following infection with HIV-1: Implications for interpreting test results and retesting after exposure.
    Clin Infect Dis. 2016.
    >> Share

  338. SERETI I, Krebs SJ, Phanuphak N, Fletcher JL, et al
    Initiation of antiretroviral therapy in early HIV infection reduces but does not abrogate chronic residual inflammation.
    Clin Infect Dis. 2016.
    >> Share

  339. BROWN L, Langelier C, Reid MJ, Rutishauser RL, et al
    Antimicrobial Resistance: A Call to Action!
    Clin Infect Dis. 2016.
    >> Share

  340. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016;63:853-67.
    >> Share

    September 2016
  341. COHEN M, Eshleman S, McCauley M, Chen Y, et al
    Antiretroviral therapy to prevent HIV acquisition: Limits of estimation from a population cohort.
    Clin Infect Dis. 2016.
    >> Share

  342. SELHORST P, Masson L, Ismail SD, Samsunder N, et al
    CErvicovaginal inflaMmation Facilitates Acquisition of less infectious HIV variants.
    Clin Infect Dis. 2016.
    >> Share

  343. LJUNGMAN P, Boeckh M, Hirsch HH, Josephson F, et al
    Definitions of CMV infection and disease in transplant patients for use in clinical trials.
    Clin Infect Dis. 2016.
    >> Share

  344. NAGGIE S, Holland D, Sulkowski MS, Thomas DL, et al
    HCV post-exposure prophylaxis in the healthcare worker: Why DAAs don't change a thing.
    Clin Infect Dis. 2016.
    >> Share

  345. BORDONI V, Sacchi A, Cimini E, Casetti R, et al
    Different Role of IL-7 and IL-18 in Affecting Lymphoid Hematopoietic Progenitor Cells and CD4 Homeostasis in Naive Primary and Chronic HIV-Infected patients.
    Clin Infect Dis. 2016.
    >> Share

  346. BROCK JB, Mena LA
    HIV Medicine Residency Training Correspondence.
    Clin Infect Dis. 2016.
    >> Share

  347. BOERMA RS, Boender TS, Bussink AP, Calis JC, et al
    Suboptimal viral suppression rates among HIV-infected children in low- and middle-income countries: a meta-analysis.
    Clin Infect Dis. 2016.
    >> Share

  348. CASTILLO-MANCILLA JR, Brown TT, Erlandson KM, Palella FJ Jr, et al
    Suboptimal cART Adherence is Associated with Higher Levels of Inflammation Despite HIV Suppression.
    Clin Infect Dis. 2016.
    >> Share

  349. THOMPSON-PAUL AM, Lichtenstein KA, Armon C, Palella FJ Jr, et al
    Cardiovascular disease risk prediction in the HIV Outpatient Study.
    Clin Infect Dis. 2016.
    >> Share

  350. BORGES AH, Neuhaus J, Babiker AG, Henry K, et al
    Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection.
    Clin Infect Dis. 2016.
    >> Share

  351. SMITH DM, Nakazawa M, Freeman ML, Anderson CM, et al
    Asymptomatic CMV Replication during Early HIV-infection is Associated with Lower CD4/CD8 Ratio during HIV Treatment.
    Clin Infect Dis. 2016.
    >> Share

    August 2016
  352. JUDD A, Le Prevost M, Melvin D, Arenas-Pinto A, et al
    Cognitive function in young people with and without perinatal HIV in the AALPHI cohort in England: the role of non-HIV related factors.
    Clin Infect Dis. 2016.
    >> Share


  353. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    Clin Infect Dis. 2016.
    >> Share

  354. TINCATI C, Rainone V, Comi L, Pandolfo A, et al
    Cell-Mediated Immunity in HIV-Infected Males with HPV-Related Anal Dysplastic Lesions.
    Clin Infect Dis. 2016.
    >> Share

  355. JOHNSON G, Levison J, Malek J
    Should providers discuss breastfeeding with women living with HIV in high-income countries? An ethical analysis.
    Clin Infect Dis. 2016.
    >> Share

  356. TAO G, Hoover KW, Nye MB, Peters P, et al
    Rectal infection with Neisseria gonorrhoeae and Chlamydia trachomatis in males in the United States.
    Clin Infect Dis. 2016.
    >> Share

  357. DRABO EF, Hay JW, Vardavas R, Wagner ZR, et al
    A Cost-Effectiveness Analysis Of Pre-Exposure Prophylaxis For The Prevention Of HIV Among Los Angeles County Men Who Have Sex With Men.
    Clin Infect Dis. 2016.
    >> Share

  358. MAYER KH, Krakower DS
    Can We Afford to Control the HIV Epidemic with Antiretrovirals? Can We Afford Not to Do So?
    Clin Infect Dis. 2016.
    >> Share

  359. GREBELY J, Mauss S, Brown A, Bronowicki JP, et al
    Efficacy and safety of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic HCV genotype 1 infection receiving opioid substitution therapy: Analysis of Phase 3 ION trials.
    Clin Infect Dis. 2016.
    >> Share

  360. POTARD V, Simon A, Lacombe JM, Parienti JJ, et al
    Switching to Raltegravir From a Virologically Effective Boosted Protease Inhibitor Regimen: A Comparative Effectiveness Analysis From the French Hospital Database on HIV (FHDH-ANRS CO4).
    Clin Infect Dis. 2016.
    >> Share

  361. SALINAS JL, Rentsch C, Marconi VC, Tate J, et al
    Baseline, Time-updated, and Cumulative HIV Care Metrics for Predicting Acute Myocardial Infarction and All-Cause Mortality.
    Clin Infect Dis. 2016.
    >> Share


  362. Changing incidence and risk factors for Kaposi sarcoma by time since starting antiretroviral therapy: Collaborative analysis of 21 European cohort studies.
    Clin Infect Dis. 2016.
    >> Share

  363. INGILIZ P, Christensen S, Kimhofer T, Hueppe D, et al
    Sofosbuvir and Ledipasvir for 8 weeks for the treatment of chronic hepatitis C virus infection in HCV-mono-infected and HIV-HCV co-infected individuals - Results from the German hepatitis C cohort (GECCO-01).
    Clin Infect Dis. 2016.
    >> Share

  364. NAHID P, Dorman SE, Alipanah N, Barry PM, et al
    Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
    Clin Infect Dis. 2016.
    >> Share

  365. WITTKOP L
    Endstage liver disease in HIV infection: an avoidable burden?
    Clin Infect Dis. 2016.
    >> Share

  366. KLEIN MB, Althoff KN, Jing Y, Lau B, et al
    Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras.
    Clin Infect Dis. 2016.
    >> Share

  367. ABRAVANEL F, Metivier S, Chauveau M, Peron JM, et al
    Transmission of HCV NS5A inhibitor-resistant variants among HIV-infected men who have sex with men.
    Clin Infect Dis. 2016.
    >> Share

  368. KAMSTRA R, Azoulay L, Steele R, Klein MB, et al
    Hospitalizations in immigrants and non-immigrants diagnosed with chronic hepatitis C infection in Quebec.
    Clin Infect Dis. 2016.
    >> Share

    July 2016
  369. BOETTIGER DC, Muktiarti D, Kurniati N, Truong KH, et al
    Early height and weight changes in children using cotrimoxazole prophylaxis with antiretroviral therapy.
    Clin Infect Dis. 2016.
    >> Share

  370. HAAS AD, Msukwa MT, Egger M, Tenthani L, et al
    Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's "Option B+" programme.
    Clin Infect Dis. 2016.
    >> Share

  371. MUKERJI SS, Locascio JJ, Misra V, Lorenz DR, et al
    Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy.
    Clin Infect Dis. 2016.
    >> Share

  372. HANNA DB, Ramaswamy C, Kaplan RC, Kizer JR, et al
    Trends in cardiovascular disease mortality among persons with HIV in New York City, 2001-2012.
    Clin Infect Dis. 2016.
    >> Share

  373. WEIJSENFELD AM, Smit C, Cohen S, Wit FW, et al
    Virological and Social outcomes of HIV-infected adolescents and young adults in the Netherlands before and after transition to adult care.
    Clin Infect Dis. 2016.
    >> Share

  374. BARLOW-MOSHA L, Angelidou K, Lindsey J, Archary M, et al
    Nevirapine- vs Lopinavir/Ritonavir-based Antiretroviral Therapy in HIV-infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.
    Clin Infect Dis. 2016.
    >> Share


  375. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016.
    >> Share

  376. WYLES DL, Sulkowski MS, Dieterich D
    Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.
    Clin Infect Dis. 2016;63 Suppl 1:S3-S11.
    >> Share

  377. MACBRAYNE CE, Kiser JJ
    Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV.
    Clin Infect Dis. 2016;63 Suppl 1:S12-23.
    >> Share

  378. WANGPATHARAWANIT P, Sungkanuparph S
    Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial.
    Clin Infect Dis. 2016.
    >> Share

  379. ROWAN SE, Rogers M, Bayer J, Smith L, et al
    Treatment of HCV in HIV coinfected individuals in real world clinical settings: results from two large HIV care clinics.
    Clin Infect Dis. 2016.
    >> Share

  380. AL-KINDI SG, Zidar DA, McComsey GA, Longenecker CT, et al
    Gender differences in statin prescription rate among patients living with HIV and HCV.
    Clin Infect Dis. 2016.
    >> Share

    June 2016
  381. CREPAZ N, Tang T, Marks G, Mugavero MJ, et al
    Durable Viral Suppression and Transmission Risk Potential among Persons with Diagnosed HIV Infection: United States, 2012-2013.
    Clin Infect Dis. 2016.
    >> Share

  382. WEISER J, Beer L, West BT, Duke CC, et al
    Qualifications, Demographics, Satisfaction, and Future Capacity of the HIV Care Provider Workforce in the United States, 2013-2014.
    Clin Infect Dis. 2016.
    >> Share

  383. LYKINS J, Wang K, Wheeler K, Clouser F, et al
    Understanding Toxoplasmosis in the United States Through "Large Data" Analyses.
    Clin Infect Dis. 2016.
    >> Share

  384. WADA NI, Bream JH, Martinez-Maza O, Macatangay B, et al
    Inflammatory biomarkers predict mortality among HIV-suppressed men: a multisite prospective cohort study.
    Clin Infect Dis. 2016.
    >> Share

  385. LOW AJ, Mburu G, Welton NJ, May MT, et al
    Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: a Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2016.
    >> Share

  386. BLOCH M, Kamminga J, Jayewardene A, Bailey M, et al
    A Screening Strategy for HIV-Associated Neurocognitive Disorders (HAND) that Accurately Identifies Patients Requiring Neurological Review.
    Clin Infect Dis. 2016.
    >> Share

  387. KEATING SM, Pilcher CD, Busch MP
    Timing is Everything - Shortcomings of Current HIV Diagnostics in the Early Treatment Era.
    Clin Infect Dis. 2016.
    >> Share

  388. DE SOUZA MS, Pinyakorn S, Akapirat S, Pattanachaiwit S, et al
    Initiation of Antiretroviral Therapy during Acute HIV-1 Infection leads to A High Rate of Non-Reactive HIV Serology.
    Clin Infect Dis. 2016.
    >> Share

  389. SOGNI P, Gilbert C, Lacombe K, Piroth L, et al
    All-oral DAA regimens in HIV-HCV coinfected cirrhotic patients are efficient and safe. Real-life results from the prospective ANRS CO13 - HEPAVIH cohort.
    Clin Infect Dis. 2016.
    >> Share

  390. ISA SE, Oche AO, Kang'ombe AR, Okopi JA, et al
    HIV and risk of type 2 diabetes in a large adult cohort in Jos, Nigeria.
    Clin Infect Dis. 2016.
    >> Share

  391. KASSAYE SG, Grossman Z, Balamane M, Johnston-White B, et al
    Transmitted HIV Drug Resistance High and Longstanding in Metropolitan Washington, D.C.
    Clin Infect Dis. 2016.
    >> Share

  392. GJAERDE LI, Shepherd L, Jablonowska E, Lazzarin A, et al
    Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study.
    Clin Infect Dis. 2016.
    >> Share

  393. SCOTT C, Cavanaugh JS, Pratt R, Silk BJ, et al
    Human tuberculosis caused by Mycobacterium bovis in the United States, 2006-2013.
    Clin Infect Dis. 2016.
    >> Share

  394. HOOTS BE, Finlayson T, Nerlander L, Paz-Bailey G, et al
    Willingness to Take, Use of, and Indications for Pre-Exposure Prophylaxis among Men Who Have Sex with Men - 20 U.S. Cities, 2014.
    Clin Infect Dis. 2016.
    >> Share

  395. HEIDARY M, Nasiri MJ, Goudarzi M
    Why the HIV/AIDS prevalence was increased in Iran, despite the decreasing in the USA?
    Clin Infect Dis. 2016.
    >> Share

    May 2016
  396. COOPER C, Naggie S, Saag M, Yang JC, et al
    Successful Retreatment of HCV in Patients Coinfected with HIV Who Failed 12 Weeks of Ledipasvir/Sofosbuvir.
    Clin Infect Dis. 2016.
    >> Share

  397. KELLY EM, Dodge JL, Sarkar M, French AL, et al
    Marijuana Use is not Associated with Progression to Advanced Liver Fibrosis in HIV/HCV Coinfected Women.
    Clin Infect Dis. 2016.
    >> Share

  398. GIORDANO TP, Cully J, Amico KR, Davila JA, et al
    A randomized trial to test a peer mentor intervention to improve outcomes in persons hospitalized with HIV infection.
    Clin Infect Dis. 2016.
    >> Share

  399. OLDENBURG CE, Barnighausen T, Tanser F, Iwuji CC, et al
    Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa.
    Clin Infect Dis. 2016.
    >> Share

  400. MARQUINE MJ, Montoya JL, Umlauf A, Fazeli PL, et al
    The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.
    Clin Infect Dis. 2016.
    >> Share

  401. OFOTOKUN I, Titanji K, Lahiri CD, Vunnava A, et al
    A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced Bone Loss in Treatment-naive HIV-infected Patients: a Phase IIb Trial.
    Clin Infect Dis. 2016.
    >> Share

  402. GLAUBIUS RL, Hood G, Penrose KJ, Parikh UM, et al
    Cost-Effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
    Clin Infect Dis. 2016.
    >> Share

  403. MEHTA SR, Murrell B, Anderson CM, Kosakovsky Pond SL, et al
    Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California.
    Clin Infect Dis. 2016.
    >> Share

  404. REIDY W, Agarwal M, Chege D, Lamb M, et al
    Retention in Care Among HIV-Infected Patients on Antiretroviral Therapy and Among Those Not on Antiretroviral Therapy in Eastern Africa.
    Clin Infect Dis. 2016.
    >> Share

  405. TUCKER JD, Cao B, Li H, Tang S, et al
    Social Media Interventions to Promote HIV Testing.
    Clin Infect Dis. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016